137 related articles for article (PubMed ID: 1929278)
1. Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.
Davidson RJ; Zhanel GG; Phillips R; Hoban DJ
Antimicrob Agents Chemother; 1991 Jun; 35(6):1261-3. PubMed ID: 1929278
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
[TBL] [Abstract][Full Text] [Related]
3. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
[TBL] [Abstract][Full Text] [Related]
4. The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect.
Davidson RJ; Drobot GR; Karlowsky JA; Zhanel GG; Philips R; Hoban DJ
J Antimicrob Chemother; 1994 Sep; 34(3):363-70. PubMed ID: 7829410
[TBL] [Abstract][Full Text] [Related]
5. Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus.
Giamarellou-Bourboulis EJ; Sambatakou H; Grecka P; Chryssouli Z; Giamarellou H
Diagn Microbiol Infect Dis; 1999 Aug; 34(4):301-7. PubMed ID: 10459481
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Smith KR; Cobbs CG
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
[TBL] [Abstract][Full Text] [Related]
8. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
[TBL] [Abstract][Full Text] [Related]
10. [Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1996 May; 45(2):56-8. PubMed ID: 8756401
[TBL] [Abstract][Full Text] [Related]
11. Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.
Majtán V; Majtánová L
Folia Microbiol (Praha); 1997; 42(4):327-32. PubMed ID: 9449780
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
Foster JK; Lentino JR; Strodtman R; DiVincenzo C
Antimicrob Agents Chemother; 1986 Dec; 30(6):823-7. PubMed ID: 3643771
[TBL] [Abstract][Full Text] [Related]
13. Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.
Fuursted K
Antimicrob Agents Chemother; 1997 Aug; 41(8):1693-6. PubMed ID: 9257743
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
Allemandi DA; Alovero FL; Manzo RH
J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
[TBL] [Abstract][Full Text] [Related]
15. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Majtán V; Hostacká A
Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Smith SM
Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
[TBL] [Abstract][Full Text] [Related]
19. Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.
Chaudhry AZ; Knapp CC; Sierra-Madero J; Washington JA
Antimicrob Agents Chemother; 1990 Sep; 34(9):1843-5. PubMed ID: 2285304
[TBL] [Abstract][Full Text] [Related]
20. Gepotidacin (GSK2140944)
Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]